Diagnostic performance of neuromelanin-sensitive magnetic resonance imaging for patients with Parkinson’s disease and factor analysis for its heterogeneity: a systematic review and meta-analysis

@article{Cho2020DiagnosticPO,
  title={Diagnostic performance of neuromelanin-sensitive magnetic resonance imaging for patients with Parkinson’s disease and factor analysis for its heterogeneity: a systematic review and meta-analysis},
  author={Se Jin Cho and Yun Jung Bae and Jong-Min Kim and Donghyun Kim and Sung Hyun Baik and Leonard Sunwoo and Byung Se Choi and Jae Hyoung Kim},
  journal={European Radiology},
  year={2020},
  volume={31},
  pages={1268 - 1280}
}
To determine the diagnostic performance of neuromelanin-sensitive magnetic resonance imaging discriminating between patients with Parkinson’s disease and normal healthy controls and to identify factors causing heterogeneity influencing the diagnostic performance. A systematic literature search in the Ovid-MEDLINE and EMBASE databases was performed for studies reporting the relevant topic before February 17, 2020. The pooled sensitivity and specificity values with their 95% confidence intervals… 

Neuromelanin-Sensitive Magnetic Resonance Imaging in Schizophrenia: A Meta-Analysis of Case-Control Studies

TLDR
The results support neuromelanin as a candidate biomarker for dopaminergic dysfunction in schizophrenia in large, longitudinal cohorts and address potential effects of disease state, medication and correlations with symptoms.

STAGE as a multicenter, multivendor protocol for imaging Parkinson’s disease: a validation study on healthy controls

TLDR
The ability to collect data across manufacturers at different hospitals using STAGE provides an impetus for broader movement disorder studies using MRI.

Application of Neuromelanin MR Imaging in Parkinson Disease.

TLDR
MRI has been used to develop biomarkers for movement disorders such as Parkinson disease (PD) and other neurodegenerative disorders with parkinsonism such as progressive supranuclear palsy and multiple system atrophy, whose integrity can be assessed from its contrast and volume.

Editorial for “Cross‐Scanner Harmonization of Neuromelanin‐Sensitive MRI for Multisite Studies”

TLDR
It is demonstrated that employing a conventional harmonization method (ComBat) leads to removal of unwanted nonbiological variability (such as scanner effects) while maintaining biological variability associated with age in a large sample of healthy subjects at three study sites and five different scanners, which suggested that biologically meaningful variability was preserved by this procedure.

Imaging Dopaminergic Neurotransmission in Neurodegenerative Disorders.

TLDR
The role of imaging of the nigrostriatal pathway, as well as of striatal receptors and dopamine release, in common neurodegenerative disorders in clinical practice and research is reviewed and novel MRI sequences as neuromelanin-sensitive MRI are promising new tools to study nigrostiatal degeneration in vivo.

Magnetic resonance imaging of the dopamine system in schizophrenia – A scoping review

For decades, aberrant dopamine transmission has been proposed to play a central role in schizophrenia pathophysiology. These theories are supported by human in vivo molecular imaging studies of

Regional Selectivity of Neuromelanin Changes in the Substantia Nigra in Atypical Parkinsonism

Neurodegeneration in the substantia nigra pars compacta (SNc) in parkinsonian syndromes may affect the nigral territories differently.

References

SHOWING 1-10 OF 61 REFERENCES

Quantitative Analysis Versus Visual Assessment of Neuromelanin MR Imaging for the Diagnosis of Parkinson's disease.

TLDR
Visual inspection of neuromelanin-sensitive MR images by experienced neuroradiologists provides comparable results to quantitative width measurement in the detection of early stage PD SN changes and may become a useful tool in clinical practice.

Combined Visualization of Nigrosome-1 and Neuromelanin in the Substantia Nigra Using 3T MRI for the Differential Diagnosis of Essential Tremor and de novo Parkinson's Disease

TLDR
The findings demonstrate that visual analyses combing NM and N1 imaging in theSN may aid in differential diagnosis of PD and ET and suggest that patients with PD exhibit larger iron deposits in the SN than those with ET.

Quantifying changes in nigrosomes using quantitative susceptibility mapping and neuromelanin imaging for the diagnosis of early-stage Parkinson's disease.

TLDR
Comprehensive MRI assessment of the abnormality involving the nigrosomes can yield a high diagnostic performance for early-stage PD.

Evaluation of Parkinson’s disease by neuromelanin-sensitive magnetic resonance imaging and 123I-FP-CIT SPECT

TLDR
It is concluded that DaTSCAN is more suitable for the evaluation of the clinical motor severity and would be more useful for the management of PD patients than NmMRI.

3D neuromelanin-sensitive magnetic resonance imaging with semi-automated volume measurement of the substantia nigra pars compacta for diagnosis of Parkinson’s disease

TLDR
The 3D turbo field echo sequence can distinguish the PD group from the control group with high sensitivity and specificity, especially for early stage of PD.

Comparative Study of MRI Biomarkers in the Substantia Nigra to Discriminate Idiopathic Parkinson Disease

TLDR
The combination of neuromelanin signal and volume changes with fractional anisotropy measurements in the substantia nigra showed excellent diagnostic accuracy and indicates that these techniques are promising for clinical practice.

Neuromelanin Magnetic Resonance Imaging in Parkinson's Disease and Multiple System Atrophy

TLDR
The results indicate a potential diagnostic value of neuromelanin MRI to distinguish MSA patients from normal and PD patients and compare the results with those of 23 normal volunteers.

A Comparison of Substantia Nigra T1 Hyperintensity in Parkinson's Disease Dementia, Alzheimer's Disease and Age-Matched Controls: Volumetric Analysis of Neuromelanin Imaging

TLDR
The volumetric measurement of the T1 hyperintensity of SN can be an imaging marker for evaluating neuromelanin loss in neurodegenerative diseases and a differential in PDD and AD cases.
...